| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +66.67% | +0.15% | -1.93% | +2.08% | +2.94% | — |
| 14d | 3 | +0.00% | -6.69% | -1.76% | -4.92% | -7.95% | — |
| 30d | 3 | +33.33% | -0.58% | +0.09% | -0.68% | -13.32% | — |
| 60d | 3 | +33.33% | +3.55% | +0.97% | +2.58% | -7.67% | — |
| 90d | 3 | +0.00% | -14.41% | -0.42% | -13.99% | -20.59% | — |
| 180d | 3 | +33.33% | +527.50% | +4.12% | +523.38% | -36.80% | — |
| 1y | 3 | +33.33% | +314.94% | +6.46% | +308.47% | -65.87% | — |
| 2y | 3(1 pending) | +50.00% | +303.45% | +23.86% | +279.60% | +279.60% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CUE CUE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 450,000 | — | — | 450,000 | Mar 21, 2025 | Mar 25, 2025 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 30,000 | $1.03 | $30.9K | 164,578 | Dec 16, 2024 | Dec 18, 2024 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 400,000 | — | — | 400,000 | Mar 6, 2024 | Mar 8, 2024 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 3,000 | $2.86 | $8.6K | 134,578 | Aug 14, 2023 | Aug 16, 2023 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 450,000 | — | — | 450,000 | Jul 21, 2023 | Jul 25, 2023 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 324,000 | — | — | 324,000 | Feb 16, 2023 | Feb 21, 2023 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | SALE CHIEF EXECUTIVE OFFICER | 75,000 | — | — | 0 | Mar 31, 2022 | Apr 4, 2022 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 75,000 | — | — | 173,700 | Mar 31, 2022 | Apr 4, 2022 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | SALE CHIEF EXECUTIVE OFFICER | 32,122 | $4.88 | $156.8K | 141,578 | Mar 31, 2022 | Apr 4, 2022 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | SALEGRANT Gift | 10,000 | — | — | 131,578 | Mar 31, 2022 | Apr 4, 2022 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 100,000 | Mar 25, 2022 | Mar 29, 2022 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | SALE CHIEF EXECUTIVE OFFICER | 75,000 | — | — | 75,000 | Sep 30, 2021 | Oct 8, 2021 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 75,000 | — | — | 130,377 | Sep 30, 2021 | Oct 8, 2021 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | SALE CHIEF EXECUTIVE OFFICER | 31,677 | $14.57 | $461.5K | 98,700 | Sep 30, 2021 | Oct 8, 2021 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | PURCHASE CHIEF EXECUTIVE OFFICER | 3,400 | $14.72 | $50.1K | 55,377 | Sep 24, 2021 | Sep 27, 2021 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 85,000 | — | — | 85,000 | Feb 10, 2021 | Feb 12, 2021 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Feb 5, 2020 | Feb 12, 2020 ↗ | View → |
| CUE CUE BIOPHARMA, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Feb 5, 2020 | Feb 12, 2020 ↗ | View → |